CE webinars

Upon completion of this CE program, the audience will have an understanding of CAR-T cell treatment and how it works.  The CE program will provide information on the role of CAR-T cell therapy across the oncology landscape, including current drugs in the market and pipeline drugs.

Recognizing the expanding definition of family, this continuing education program is designed to support knowledge and discussion about the multiple avenues by which members of the LGBTQ+ community can pursue conception, including challenges to access and opportunities to break down barriers.

This program reviews the potential etiologies and nutritional requirements of patients with Crohn's disease. The program covers the role of specialized nutrition support, including home nutrition support in the treatment and management of Crohn's. 

Upon completion of this CE program, the audience will have a disease background on Acute Myeloid Leukemia including diagnosis, epidemiology, risk factors, and symptoms of AML.  The CE program will provide information on treatment options available to AML patients, including current drugs in the market and pipeline drugs.

This program will review and familiarize the audience with enteral feeding tubes. The history of feeding tube placement and types of access devices will be described, as well as an explanation of the surgical methods for percutaneous feeding tube placement. Lastly, the impact of the feeding tubes on patient outcomes and quality of life will be explored.

Infection remains a significant cause of morbidity and mortality in blood cell transplantation (BCT) recipients. This program reviews common bacterial, fungal and viral infections in blood cell transplant recipient. It also covers patient assessment, nursing interventions, and therapy options. 

This presentation provides an overview of the factors contributing to the development of gastroparesis and its pathophysiology. Also discussed is the disease's various drug procedural and nutrition treatments.

This program defines febrile neutropenia relating to infections in oncology, and identifies its signs and symptoms. It also reviews antibiotic treatment protocols, and discusses patient and drug considerations for home infusion therapy. 

This program reviews the nuances involved in transitioning pediatric patients receiving parenteral and enteral nutrition therapies from the acute care setting to home. It covers considerations for treating pediatric malnutrition, optimizing nutrition support, access device selection options, and reviews homecare considerations to optimize insurance coverage.

Upon completion of this CE program, the audience will have a disease background on Narcolepsy including prevalence, diagnosis, co-morbid conditions and symptoms of Narcolepsy.  The CE program will also provide information on goals of treatment, including current and future medications available to treat Patients with Narcolepsy (PWN).